Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 6-(4-chlorophenyl)-2,3-dihydro-N-[(1S)-2-hydroxy-1-methylethyl]-2-(1-methyl-1H-pyrazol-4-yl)-3-oxo-4 | 2242464-44-2 | MFCD32693912 | >98.0% | C18H18ClN5O3 | 10MG
SDP

Supplier:  Medchemexpress LLC HY13582910MG

Encompass_Preferred

BAY 2416964 is a small-molecule aryl hydrocarbon receptor (AhR) antagonist developed as a clinical-stage oncology candidate. It inhibits AhR signaling in vitro, has shown cellular potency in reported assays, and has been evaluated in early-phase clinical studies as an immunomodulatory agent to enhance anti-tumor immune responses.

  • Small-molecule aryl hydrocarbon receptor antagonist.
  • Demonstrated cellular potency, reported IC50 ~341 nM.
  • Investigated in early-phase clinical studies for solid tumors.
  • High chemical purity typical for supplied samples (>98.0%).
  • Suitable for preclinical pharmacology and mechanism-of-action studies.
  • Molecular formula C18H18ClN5O3; molecular weight ~387.8.

Catalog No. 50-002-58766


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.